Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Raskob · SciRah

Researcher profile · Semantic Scholar

G. Raskob

Share profile

G. Raskob — researcher profile on SciRah

h-index: 89
Works: 318
Citations: 46K

Most-cited papers

Global Burden of Thrombosis: Epidemiologic Aspects.
A. Wendelboe, G. Raskob
2016Circulation Research1,204 citations Open access
Semantic Scholar
Edoxaban for the Treatment of Cancer‐Associated Venous Thromboembolism
G. Raskob, N. van Es, P. Verhamme, M. Carrier +15 more
2017New England Journal of Medicine885 citations Open access
Semantic Scholar
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
G. Raskob, N. van Es, P. Verhamme, M. Carrier +3 more
2019Journal of Vascular Surgery: Venous and Lymphatic Disorders578 citations Open access
Semantic Scholar
The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs
S. Grosse, R. Nelson, K. Nyarko, L. Richardson +1 more
2015Thrombosis Research483 citations Open access
Semantic Scholar
Abelacimab for Prevention of Venous Thromboembolism.
P. Verhamme, B. Yi, A. Segers, J. Salter +4 more
2021New England Journal of Medicine229 citations Open access
Semantic Scholar
Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.
J. Weitz, R. Bauersachs, B. Becker, S. Berkowitz +4 more
2020Journal of the American Medical Association (JAMA)227 citations Open access
Semantic Scholar
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness
A. Spyropoulos, W. Ageno, G. Albers, G. Elliott +9 more
2018New England Journal of Medicine225 citations Open access
Semantic Scholar
Milvexian for the Prevention of Venous Thromboembolism
J. Weitz, J. Strony, W. Ageno, D. Gailani +7 more
2021New England Journal of Medicine202 citations Open access
Semantic Scholar
Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study
N. Kraaijpoel, M. Di Nisio, F. Mulder, N. van Es +18 more
2018Thrombosis and Haemostasis201 citations Open access
Semantic Scholar
Oral apixaban for the treatment of venous thromboembolism in cancer patients: results from the AMPLIFY trial
G. Agnelli, H. Büller, A. Cohen, A. Gallus +5 more
2015Journal of Thrombosis and Haemostasis201 citations Open access
Semantic Scholar
Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial.
G. Raskob, N. van Es, A. Segers, P. Angchaisuksiri +10 more
2016The Lancet Haematology155 citations
Semantic Scholar
Global public awareness of venous thromboembolism
A. Wendelboe, Micah McCumber, E. Hylek, H. Büller +2 more
2015Journal of Thrombosis and Haemostasis138 citations Open access
Semantic Scholar
Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis
A. Spyropoulos, Concetta Lipardi, Jianfeng Xu, Colleen Peluso +4 more
2020TH Open133 citations Open access
Semantic Scholar
Edoxaban for treatment of venous thromboembolism in patients with cancer
N. van Es, M. Di Nisio, Suzanne M. Bleker, A. Segers +19 more
2015Thrombosis and Haemostasis90 citations Open access
Semantic Scholar
Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study.
F. Mulder, N. van Es, N. Kraaijpoel, M. Di Nisio +17 more
2019Thrombosis Research76 citations Open access
Semantic Scholar
The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE
G. Raskob, A. Spyropoulos, J. Zrubek, W. Ageno +11 more
2016Thrombosis and Haemostasis72 citations Open access
Semantic Scholar
Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score
M. D. de Winter, H. Büller, M. Carrier, A. Cohen +10 more
2023European Heart Journal65 citations Open access
Semantic Scholar
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism
F. Khan, T. Tritschler, M. Kimpton, P. Wells +33 more
2021Annals of Internal Medicine65 citations Open access
Semantic Scholar
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post‐hoc analysis of the Hokusai‐VTE Cancer study
M. Di Nisio, N. van Es, M. Carrier, Tzu-Fei Wang +5 more
2019Journal of Thrombosis and Haemostasis65 citations Open access
Semantic Scholar
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study
A. Spyropoulos, Concetta Lipardi, Jianfeng Xu, Wentao Lu +8 more
2019Clinical and applied thrombosis/hemostasis63 citations Open access
Semantic Scholar
New paradigms in venous thromboprophylaxis of medically ill patients
A. Spyropoulos, G. Raskob
2017Thrombosis and Haemostasis60 citations
Semantic Scholar
Extended duration of anticoagulation with edoxaban in patients with venous thromboembolism: a post-hoc analysis of the Hokusai-VTE study.
G. Raskob, W. Ageno, A. Cohen, M. P. Brekelmans +9 more
2016The Lancet Haematology58 citations
Semantic Scholar
Treatment of Cancer-Associated Venous Thromboembolism with Low-Molecular-Weight Heparin or Direct Oral Anticoagulants: Patient Selection, Controversies, and Caveats.
C. O'Connell, C. Escalante, S. Goldhaber, R. McBane +2 more
2020The Oncologist55 citations Open access
Semantic Scholar
Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients
A. Spyropoulos, W. Ageno, G. W. Albers, C. Elliott +9 more
2020Journal of the American College of Cardiology53 citations Open access
Semantic Scholar
Diversity and severity of adverse reactions to quinine: A systematic review
Nathan W. Liles, Evaren E. Page, Amber L. Liles, S. Vesely +2 more
2016American journal of hematology/oncology46 citations Open access
Semantic Scholar
Prediction of major and clinically relevant bleeding in patients with VTE treated with edoxaban or vitamin K antagonists
M. Di Nisio, G. Raskob, H. Büller, M. Grosso +3 more
2017Thrombosis and Haemostasis45 citations Open access
Semantic Scholar
Clinical implications of incidental venous thromboembolism in cancer patients
F. Mulder, M. Di Nisio, C. Ay, M. Carrier +13 more
2019European Respiratory Journal43 citations Open access
Semantic Scholar
Dose reduction of edoxaban preserves efficacy and safety for the treatment of venous thromboembolism
P. Verhamme, P. Wells, A. Segers, W. Ageno +8 more
2016Thrombosis and Haemostasis42 citations Open access
Semantic Scholar
Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction
Tzu-Fei Wang, A. Khorana, G. Agnelli, D. Bloomfield +12 more
2023The Oncologist35 citations Open access
Semantic Scholar
Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension.
P. Wells, M. Prins, B. Levitan, J. Beyer-Westendorf +10 more
2016Chest35 citations Open access
Semantic Scholar
Thrombosis in Cancer: Research Priorities Identified by a National Cancer Institute/National Heart, Lung, and Blood Institute Strategic Working Group.
N. Key, A. Khorana, N. Mackman, O. McCarty +7 more
2016Cancer Research34 citations Open access
Semantic Scholar
The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V—Special Situations
R. de Caterina, W. Ageno, G. Agnelli, N. Chan +7 more
2018Thrombosis and Haemostasis33 citations Open access
Semantic Scholar
Recurrent venous thromboembolism in patients with pulmonary embolism and right ventricular dysfunction: a post-hoc analysis of the Hokusai-VTE study.
M. P. Brekelmans, W. Ageno, L. Beenen, B. Brenner +12 more
2016The Lancet Haematology32 citations
Semantic Scholar
Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients
G. Raskob, A. Spyropoulos, A. Cohen, J. Weitz +10 more
2021Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease30 citations Open access
Semantic Scholar
Incidence of Venous Thromboembolism in a Racially Diverse Population of Oklahoma County, Oklahoma
A. Wendelboe, J. Campbell, K. Ding, D. Bratzler +3 more
2021Thrombosis and Haemostasis30 citations Open access
Semantic Scholar
Impact of age, comorbidity, and polypharmacy on the efficacy and safety of edoxaban for the treatment of venous thromboembolism: An analysis of the randomized, double-blind Hokusai-VTE trial.
T. Vanassche, P. Verhamme, P. Wells, A. Segers +12 more
2018Thrombosis Research30 citations
Semantic Scholar
Edoxaban for Cancer-Associated Venous Thromboembolism.
G. Raskob, H. Büller, A. Segers
2018New England Journal of Medicine29 citations Open access
Semantic Scholar
Long‐term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta‐analysis
F. Khan, T. Tritschler, M. Kimpton, P. Wells +34 more
2021Journal of Thrombosis and Haemostasis28 citations Open access
Semantic Scholar
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists
Suzanne M. Bleker, M. P. Brekelmans, E. Eerenberg, A. Cohen +3 more
2017Thrombosis and Haemostasis27 citations Open access
Semantic Scholar
Risk Scores for Occult Cancer in Patients with Venous Thromboembolism: A Post Hoc Analysis of the Hokusai-VTE Study
N. Kraaijpoel, N. van Es, G. Raskob, H. Büller +5 more
2018Thrombosis and Haemostasis24 citations
Semantic Scholar
Clinical impact and course of major bleeding with edoxaban versus vitamin K antagonists
M. P. Brekelmans, Suzanne M. Bleker, R. Bauersachs, Z. Boda +9 more
2016Thrombosis and Haemostasis22 citations Open access
Semantic Scholar
Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective
A. Spyropoulos, W. Ageno, A. Cohen, C. M. Gibson +2 more
2020Thrombosis and Haemostasis19 citations
Semantic Scholar
Thromboprophylaxis with Rivaroxaban in Acutely Ill Medical Patients with Renal Impairment: Insights from the MAGELLAN and MARINER Trials
J. Weitz, G. Raskob, A. Spyropoulos, T. Spiro +9 more
2020Thrombosis and Haemostasis18 citations Open access
Semantic Scholar
Global public awareness about atrial fibrillation
A. Wendelboe, G. Raskob, P. Angchaisuksiri, A. Blanco +11 more
2017Research and Practice in Thrombosis and Haemostasis18 citations Open access
Semantic Scholar
Cancer‐associated venous thromboembolism: Incidence and features in a racially diverse population
G. Raskob, A. Wendelboe, J. Campbell, Lance Ford +8 more
2022Journal of Thrombosis and Haemostasis17 citations Open access
Semantic Scholar
Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban
F. Bosch, F. Mulder, M. Huisman, J. Zwicker +14 more
2021Journal of Thrombosis and Haemostasis17 citations Open access
Semantic Scholar
The US Cancer Moonshot initiative.
C. Aelion, C. Airhihenbuwa, Sonia Alemagno, R. Amler +69 more
2016The Lancet Oncology17 citations Open access
Semantic Scholar
Characteristics and Outcomes in Patients with Venous Thromboembolism Taking Concomitant Anti-Platelet Agents and Anticoagulants in the AMPLIFY Trial
A. Cohen, G. Agnelli, H. Buller, A. Gallus +4 more
2019Thrombosis and Haemostasis16 citations Open access
Semantic Scholar
RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate
W. Ageno, I. Casella, C. Han, G. Raskob +7 more
2016Thrombosis and Haemostasis16 citations
Semantic Scholar
Impact of mild thrombocytopenia on bleeding and recurrent thrombosis in cancer
Rushad D. Patell, Charles Hsu, M. Shi, M. Grosso +4 more
2023Haematologica15 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Weitz×27
Invite
J. Weitz — researcher profile on SciRah
H. Büller×23
Invite
H. Büller — researcher profile on SciRah
M. Grosso×16
Invite
M. Grosso — researcher profile on SciRah
A. Segers×15
Invite
A. Segers — researcher profile on SciRah

×13

Invite

P. Verhamme — researcher profile on SciRah

Invite

W. Ageno — researcher profile on SciRah

Invite

A. Cohen — researcher profile on SciRah

Invite

M. Carrier — researcher profile on SciRah

Invite

N. van Es — researcher profile on SciRah

M. Di Nisio×10

Invite

M. Di Nisio — researcher profile on SciRah

George Zhang×10

Invite

George Zhang — researcher profile on SciRah

A. Spyropoulos×8

Invite

A. Spyropoulos — researcher profile on SciRah